Cancer Prostate Clinical Trial
— ACTI_PAIROfficial title:
Physical Activity Experiment on Male Prostate Cancer Patients : Feasibility Multicenter Study of an Innovative Follow-up by Peers
Verified date | February 2023 |
Source | Centre Hospitalier Universitaire de Saint Etienne |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Prostate cancer is the most common cancer in France (56,841 cases in 2012). Although the benefits of physical activity (PA) in cancer patients are currently well established in the scientific literature, several studies have shown that this population is not sufficiently active. Strengthen patient adherence to prevention counseling by the physical activity (PA) is emerging as a new challenge for personalized treatment in oncology. In order to encourage the engagement and maintenance in a regular PA of cancer patients, first, their experiences of physical activity (PA) practice should be considered and their initial social representations of the practice considered. Secondarily, it is also important to identify health professionals who retain a key role in defining the framework, objectives and means of action to promote lifestyle changes towards a more active lifestyle. In addition, peer mentoring appears to offer promising perspectives for promoting adherence and long-term maintenance in physical activity (PA) of cancer patients.
Status | Completed |
Enrollment | 66 |
Est. completion date | September 14, 2021 |
Est. primary completion date | September 14, 2021 |
Accepts healthy volunteers | No |
Gender | Male |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria for patient in step1, 2 and 3: - Major patient followed for prostate cancer: - located or locally advanced, - metastatic and / or resistant to castration and chemotherapy. - Cancer diagnosed at least 1 year ago - Patient affiliated or beneficiary to social security - Signed informed consent. In more, step 2 = Patient with Physical Activity for at least 1 year Exclusion Criteria: For step 1= In the course of cancer treatment (excluding hormonal therapy) For step 2= Patient in sedentary lifestyle For step 3= - In the course of cancer treatment (excluding hormonal therapy) - Cardiac or respiratory conditions contraindicating physical activity |
Country | Name | City | State |
---|---|---|---|
France | CHU Saint-Etienne | Saint-Étienne | |
France | ICLN - département de radiothérapie | Saint-Priest-en-Jarez | |
France | ICLN - Oncologie médicale | Saint-Priest-en-Jarez |
Lead Sponsor | Collaborator |
---|---|
Centre Hospitalier Universitaire de Saint Etienne | National Cancer Institute, France |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Physical Activity sessions performed | Analysis of the proportion (%) of Physical Activity sessions performed after 3 months of intervention. | At month 3 | |
Secondary | physical activity via activity actigraph | Assessment of physical activity via activity actigraph | At month 3 | |
Secondary | sedentary lifestyle via activity actigraph | Assessment of sedentary lifestyle via activity actigraph | At month 3 | |
Secondary | Patient's activation | Measure patient's activation via questionnaire Patient Activation Measure (PAM). | At month 3 | |
Secondary | brakes blocking intervention | Identification of brakes blocking intervention via interviews and Adult Physical Activity Questionnaire (APAQ). APAQ measures the sleeping time (h/night), sedentary time (h/week) and physical activity time (h/day) | At month 3 | |
Secondary | levers favoring intervention | Identification of levers favoring intervention via interviews and Adult Physical Activity Questionnaire (APAQ). APAQ measures the sleeping time (h/night), sedentary time (h/week) and physical activity time (h/day) | At month 3 | |
Secondary | Peers mobilized | Number of peers mobilized | At month 3 |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06152419 -
Patient Education Videos to Improve Patients' Experience During Radiotherapy Treatment: a National Project
|
N/A | |
Active, not recruiting |
NCT05410002 -
Diet Effect on Cancer Treatment Outcome
|
Phase 1 | |
Completed |
NCT04836221 -
Comorbidities And Reducing inEquitieS
|
N/A | |
Terminated |
NCT03157856 -
Assessment of a New Fluorescence Imaging Technique Using Biopsies From Prostate Resection
|
||
Not yet recruiting |
NCT06035731 -
Evaluation of the Medical Service by Socio-aesthetics in Oncology
|
N/A | |
Not yet recruiting |
NCT05154474 -
Assessment of Sarcopenia at Diagnosis for Patients With Previously Untreated Metastatic Cancer or Hematologic Malignancy
|
||
Active, not recruiting |
NCT06359717 -
Prospective Validation of PSMA-RADS
|
||
Recruiting |
NCT03452774 -
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
|
||
Completed |
NCT00172055 -
Study to Assess Efficacy and Safety of Zoledronic Acid and the Value of Markers of Bone Resorption in the Prediction of Bone Metastases and Cancer Treatment-induced Bone Loss (CTIBL) in Patients With Prostate Cancer on Hormone Therapy
|
Phase 3 | |
Completed |
NCT04074460 -
Volatile Anaesthesia and Perioperative Outcomes Related to Cancer Feasibility Study
|
Phase 4 |